20261-Batra, Sandeep

Sandeep Batra, M.D.

Associate Professor of Clinical Pediatrics

Email
batras@iu.edu
Phone
317-944-8784
Address
705 Riley Hospital Drive
ROC 4340
Indianapolis, IN 46202
PubMed:

Bio

Dr. Batra is the Medical Director of the leukemia program at Riley Hospital, and the institutional Principal Investigator for Children’s Oncology Group https://www.childrensoncologygroup.org/ and the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium (TACL) https://tacl.chla.usc.edu/tacl/#!/ .  He is the co-Chair of the Adolescent and Young adults (AYA) working group at the Big Ten Cancer Research Consortium https://bigtencrc.org/

His current research is focused on identifying novel targets in relapsed, drug-refractory childhood acute lymphoblastic (ALL) and myelogenous leukemia (AML), through precision genomics and investigating mechanisms of asparaginase resistance in leukemia cancer cells.  He is the institutional principal investigator for Phase-I/II clinical trials in refractory and recurrent leukemias at Riley Hospital, and a member of the National Comprehensive Cancer Network (NCCN) Pediatric ALL panel. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1496
He is a board member and medical advisor for Indiana Wish.  https://indianawish.org/

Key Publications

1. Warrick K, Althouse SK, Rahrig AR, Rupenthal J, and Batra S. Factors Associated with Prolonged Hospital Stay during Induction Chemotherapy for High Risk Pediatric Acute Lymphoblastic Leukemia. Leuk Res. 2018 Aug;71:36-42

2. Batra S. Delaying Induction Therapy in Children With Newly Diagnosed Lymphoblastic Leukemia: Is that a Viable Strategy to Decrease Early Mortality? J Pediatr Hematol Oncol. 2019 May;41(4)

3. Halbrook CJ, Thurston G, McCarthy A, Nelson BS, Sajjakulnukit P, Krall AS, Mullen PJ, Zhang L, Batra S, Viale A, Stanger BZ, Christofk HR, Zhang J, di Magliano MP, Jorgensen C, Lyssiotis CA. Clonal Heterogeneity Supports Mitochondrial Metabolism in Pancreatic Cancer - Preprint from bioRxiv, 15 May 2020; DOI: 10.1101/2020.05.15.098368

4. Minard-Colin V, Aupérin A, Pillon M, Burke GAA, Barkauskas DA, Wheatley K, Delgado RF, Alexander S, Uyttebroeck A, Bollard CM, Zsiros J, Csoka M, Kazanowska B, Chiang AK, Miles RR, Wotherspoon A, Adamson PC, Vassal G, Patte C, Gross TG et al.; European Intergroup for Childhood Non-Hodgkin Lymphoma; Children’s Oncology Group. Collaborator: Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children. N Engl J Med. 2020 Jun 4;382 (23):2207-2219

5. Pandya PH, Cheng L, Saadatzadeh MR, Bijangi-Vishehsaraei K, Tang S, Sinn AL, Trowbridge MA, Coy KL, Bailey BJ, Young CN, Ding J, Dobrota EA, Dyer S, Elmi A, Thompson Q, Barghi F, Shultz J, Albright EA, Shannon HE, Murray ME, Marshall MS, Ferguson MJ, Bertrand TE, Wurtz LD, Batra S, Li L, Renbarger JL, Pollok KE.  Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma. Cancers (Basel). 2020 Aug 26;12(9):2426. doi: 10.3390/cancers12092426. PMID: 32859084

6. Lange CS, Rahrig A, Althouse SK, Nelson RP, Batra S. Hypogammaglobulinemia in Adolescents and Young Adults with Acute Lymphoblastic Leukemia. J Adolesc Young Adult Oncol. 2020 Dec;9(6):687-692. PMID: 32668180

7. Ferguson MJ, Batra S. 50 Years Ago in The Journal of Pediatrics: Searching for Survivors-Chemotherapy for Treatment of Acute Myelogenous Leukemia. J Pediatr. 2021 Mar;230:83. PMID: 33632401

8. Jiang J, Batra S, Zhang J. Asparagine: A Metabolite to Be Targeted in Cancers. Metabolites. 2021 Jun 19;11(6):402.

9. Batra S, Ross AJ. Pediatric Mixed-Phenotype Acute Leukemia: What's New? Cancers (Basel) 2021 Sep 16;13(18):4658.

10. Belsky JA, Batra S, Stanek JR, O'Brien SH; Secondary impacts of constipation in acute lymphoblastic leukemia in U.S. children's hospitals, Pediatr Blood Cancer 2021 Nov;68(11):Epub 2021 Sep 7.

11. Jones SR, Patel RB, Rahim MQ, Althouse SK, Batra S: Venous Thromboembolic Events in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia. J Adolesc Young Adult Oncol, 2022 Feb 2., doi: 10.1089/jayao.2021.0136.

12. Srivastava S, Jiang J, Misra J, Seim G, Staschke KA, Zhong M, Zhou L, Liu Y, Chen C, Davé U, Kapur R, Batra S, Zhang C, Zhou J, Fan J, Wek RC, Zhang J. Asparagine bioavailability regulates the translation of MYC oncogene. Oncogene. 2022 Oct;41(44):4855-4865

13. Halbrook CJ, Thurston G, Boyer S, Anaraki C, Jiménez JA, McCarthy A, Steele NG, Kerk SA, Hong HS, Lin L, Law FV, Felton C, Scipioni L, Sajjakulnukit P, Andren A, Beutel AK, Singh R, Nelson BS, Van Den Bergh F, Krall AS, Mullen PJ, Zhang L, Batra S, Morton JP, Stanger BZ, Christofk HR, Digman MA, Beard DA, Viale A, Zhang J, Crawford HC, Pasca di Magliano M, Jorgensen C, Lyssiotis CA. Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells. Nat Cancer. 2022 Nov;3(11):1386-1403.

14. Elitzur S, Vora A, Burkhardt B, Inaba H, Attarbaschi A, Baruchel A, Escherich G, Gibson B, Liu HC, Loh M, Moorman AV, Möricke A, Pieters R, Uyttebroeck A, Baird S, Bartram J, Barzilai-Birenboim S, Batra S, Ben-Harosh M, Bertrand Y, Buitenkamp T, Caldwell K, Drut R, Geerlinks AV, Gilad G, Grainger J, Haouy S, Heaney N, Huang M, Ingham D, Krenova Z, Kuhlen M, Lehrnbecher T, Manabe A, Niggli F, Paris C, Revel-Vilk S, Rohrlich P, Sinno MG, Szczepanski T, Tamesberger M, Warrier R, Wolfl M, Nirel R, Izraeli S, Borkhardt A, Schmiegelow K. EBV-driven lymphoid neoplasms associated with ALL maintenance therapy: an observational study by the Ponte di Legno Group Blood. 2023 Feb 16;141 (7):743-755.

15. Differences between pediatric and adult protocols and medical centers in the treatment of acute myeloid leukemia in the United States. Underwood J, Sharaf N, O'Brien A, Batra S, Konig H, Skiles J; J Adolesc Young Adult Oncol. 2023 Apr;12(2):147-150

16. Rahim MQ, Patel RB, Jones SR, Althouse SK, Batra S: Early discharge of AYA patients during induction chemotherapy for newly diagnosed acute lymphoblastic leukemia– is it safe? J Adolesc Young Adult Oncol. 2023 Apr;12(2):271-274.

17. Co-author/panel member: National Comprehensive Cancer Network (NCCN) PDQ for pediatric acute lymphoblastic leukemia 2024 https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1496

18. Brown A, Batra S: Rare Hematologic Malignancies and Pre-Leukemic Entities in
Children and Adolescents Young Adults. Cancers 2024, 16, 997. https://doi.org/10.3390/cancers16050997

Looking for patient care?

To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.
Find a doctor